Company profile
CyDex Pharmaceuticals company profile
CyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of current therapies. It develops a portfolio of product candidates utilizing its drug formulation technology using Captisol, a group of cyclodextrins. The company's products include Geodon IM and Abilify Injection IM for bipolar disorder/schizophrenia; Vfend IV for antifungal; and Cerenia for canine motion sickness. It also develops Fosphenytoin IV and IM for status epilepticus; Melphalan IV for multiple myeloma; Topiramate IV for epilepsy; Amiodarone IV for arrhythmia; Budesonide Solution Inhalation for asthma; Clopidogrel IV for atherothrombosis; and Budesonide/Azelastine Nasal Spray for..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.captisol.com/
- Contact email
- [email protected]
- Phone number
- 877-575-5593
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 1993-01-01
Headquarters
- Headquarters
- Wonewoc, Wisconsin, United States
- Postal code
- 92121
- Country code
- US
- Continent
- North America